CULVER CITY, Calif. – Sofie Biosciences, a developer of agents and devices for the molecular imaging of disease, announced today the closing of an additional $2 million from new and existing investors. Funds will be used for the development of new PET imaging agents and for enhancements to their PET imaging systems and chemistry units. […]
Sanford, (ME) – Maine Manufacturing has been granted a $150,000 small business research, phase one award by the National Science Foundation. Scientists at Maine Manufacturing, a life science manufacturing company, in Sanford, ME was granted the money for research into a better diagnostic technology for clinical disorders such as heart disease and other inflammatory conditions. […]
Companies mark 10-year collaboration anniversary of developing innovative products for organ transplant AUSTIN, Texas – Luminex Corporation (Nasdaq: LMNX) and One Lambda, Inc., the leading producer of transplant diagnostic products, have agreed to a long-term renewal of their 10-year strategic partnership aimed at developing platforms and technologies for human leukocyte antigen (HLA) typing and antibody […]
AUSTIN, TX – Asuragen, Inc. announced today that it has entered into an exclusive agreement with Novartis to develop worldwide Armored RNA Quant® (ARQ) BCR-ABL1 RNA International Scale (IS) Calibrators and laboratory software reporting tools, intended to aid laboratories with standardization of BCR-ABL1 RT-qPCR testing to the International Scale. As part of this agreement, Asuragen […]
Manchester, United Kingdom – At the prestigious annual British Thoracic Society meeting in London on December 1st, Dr Caroline Baxter reported the highly sensitive performance of Myconostica‘s real-time PCR assay MycAssayTM Aspergillus in cystic fibrosis (CF) sputum1 which is 260% more sensitive than the currently used culture. PCR combined with Aspergillus IgG testing on blood […]
Company Intends to Commercialize In Vitro Diagnostic Products on its nCounter Platform SEATTLE, Wash. – NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced it has secured an exclusive worldwide license from Bioclassifier, LLC to develop in […]
TRENTON, ME – Bar Harbor BioTechnology announced today plans to launch a new division focused on molecular diagnostics and personalized medicine. This new division will create genetic diagnostic tests that determine an individual’s risk of developing a disease. In 2009 the company made a breakthrough using its technology that allowed it to generate a statistical […]
PARIS – At the 30th Reunion Interdisciplinaire de Chimothérapie Anti-Infectieuse (RICAI), Bruker announces that the Assistance Publique Hôpitaux de Paris (APHP) has selected Bruker’s IVD MALDI Biotyper as their exclusive MALDI-TOF mass spectrometry-based microbial identification tool. APHP is the association of all 44 public hospitals in Paris, and is the largest public health network in […]
Beerse, Belgium – Janssen Pharmaceutica N.V., (Janssen) today announced a research agreement to collaborate with GE Healthcare to develop non-invasive or minimally invasive diagnostic biosignatures to detect Alzheimer’s disease prior to the onset of clinical symptoms. Pre-symptomatic biosignatures will allow earlier diagnosis of the disease and may enable significantly earlier intervention in Alzheimer’s disease. This […]
PRINCETON, N.J. – GE Healthcare announced today a research agreement to collaborate with Janssen Pharmaceutica NV, L.L.C. (Janssen) to identify a biosignature related to Alzheimer’s disease. This research effort will combine expertise in data integration, informatics, genomics and imaging. Its goal will be to find a biosignature that may enable the detection of Alzheimer’s disease […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
